Pfizer's Paxlovid reduces Covid-19 risk in seniors regardless of vaccine status: Study - AsiaOne

JERUSALEM - Pfizer Inc's antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coron…

JERUSALEM - Pfizer Inc's antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel c… [+2359 chars]

full article...